BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17589392)

  • 21. Antiviral options for the treatment of chronic hepatitis B.
    Osborn MK; Lok AS
    J Antimicrob Chemother; 2006 Jun; 57(6):1030-4. PubMed ID: 16595637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?
    Liaw YF
    Hepatology; 2007 Feb; 45(2):266-8. PubMed ID: 17256763
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problems of and strategies in nucleotide analogues therapy for chronic hepatitis B].
    Hou JL; Zeng GB
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):381-2. PubMed ID: 16732919
    [No Abstract]   [Full Text] [Related]  

  • 24. [To evaluate treatments of chronic hepatitis B].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):402-5. PubMed ID: 16792860
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
    Núñez M; Puoti M; Camino N; Soriano V
    Clin Infect Dis; 2003 Dec; 37(12):1678-85. PubMed ID: 14689351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.
    Leung N
    Liver Int; 2011 Jan; 31 Suppl 1():85-9. PubMed ID: 21205143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
    Buster EH; Baak BC; Bakker CM; Beuers UH; Brouwer JT; Drenth JP; van Erpecum KJ; van Hoek B; Honkoop P; Kerbert-Dreteler MJ; Koek GH; van Nieuwkerk KM; van Soest H; van der Spek BW; Tan AC; Vrolijk JM; Janssen HL
    Neth J Med; 2012 Oct; 70(8):381-5. PubMed ID: 23065990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adefovir dipivoxil for hepatitis B e antigen-positive chronic hepatitis B.
    Mukherjee S
    N Engl J Med; 2003 Jun; 348(24):2468; author reply 2468. PubMed ID: 12802037
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B virus with primary resistance to adefovir.
    Chang TT; Lai CL
    N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
    [No Abstract]   [Full Text] [Related]  

  • 30. [The past, present and future treatment for chronic hepatitis B].
    Okanoue T; Minami M
    Nihon Rinsho; 2011 May; 69 Suppl 4():469-74. PubMed ID: 22096963
    [No Abstract]   [Full Text] [Related]  

  • 31. [Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].
    MMW Fortschr Med; 2009 Apr; 151(18):62-3. PubMed ID: 19769080
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment has a positive impact on the long-term evolution of chronic hepatitis B].
    Marcellin P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S99-102. PubMed ID: 21095519
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues.
    Papatheodoridis GV
    Liver Int; 2011 Jan; 31 Suppl 1():95-103. PubMed ID: 21205145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?
    You H; Wu X; Ou X; Ma H; Wang Q; Liu T; Cong M; Wang P; Wang B; Jia J
    Antivir Ther; 2011; 16(3):299-307. PubMed ID: 21555812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B: explosion of new knowledge.
    Keeffe EB
    Gastroenterology; 2007 Nov; 133(5):1718-21. PubMed ID: 17983813
    [No Abstract]   [Full Text] [Related]  

  • 36. Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
    Hadziyannis SJ
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1482. PubMed ID: 22582839
    [No Abstract]   [Full Text] [Related]  

  • 37. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
    Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
    Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatment of chronic hepatitis B.
    Lok AS
    Semin Liver Dis; 2004; 24 Suppl 1():77-82. PubMed ID: 15192805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral therapy in patients with chronic hepatitis B and cirrhosis.
    Lai CJ; Terrault NA
    Gastroenterol Clin North Am; 2004 Sep; 33(3):629-54, x-xi. PubMed ID: 15324948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral therapy for treatment-naïve hepatitis B virus patients.
    Lau DT; Membreno FE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):581-99, ix-x. PubMed ID: 15324945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.